Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

67.33 +0.38 (+0.57%)

Streaming Delayed Price Updated: 9:51 AM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

48 49 Next >

DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

July 26, 2024

Via Benzinga

This Southwest Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

July 26, 2024

Via Benzinga

Dexcom Shares Plummet Nearly 39% In Pre-Market After Lowering Full-Year Sales Outlook ↗

July 26, 2024

During an analyst call, Dexcom executives attributed the forecast cut to fewer new customers and lower revenue per customer than expected.

Via Benzinga

US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data ↗

July 26, 2024

After the severe pounding the tech space received in the past three sessions, it might be rebound time. However, any recovery will largely hinge on whether key inflation data confirms the continued...

Via Benzinga

Topics Economy

$100 Invested In DexCom 10 Years Ago Would Be Worth This Much Today ↗

July 25, 2024

Via Benzinga

NASDAQ:DXCM: a strong growth stock preparing for the next leg up?. ↗

July 15, 2024

DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?.

Via Chartmill

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 26, 2024

Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!

Via InvestorPlace

Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today? ↗

July 26, 2024

Insulet Corporation shares are rising after the company reported stronger-than-expected second-quarter revenue, driven by high demand for Omnipod 5 and a raised full-year revenue outlook.

Via Benzinga

Get Your Money Out of These 3 Nasdaq Stocks by the End of July ↗

July 26, 2024

Discover why these three Nasdaq stocks may be worth selling at their current price levels.

Via InvestorPlace

Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

July 26, 2024

Via Benzinga

What Analysts Are Saying About DexCom Stock ↗

July 12, 2024

Via Benzinga

Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years ↗

July 05, 2024

Via Benzinga

Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase. ↗

June 24, 2024

Why DEXCOM INC (NASDAQ:DXCM) Is a Promising High-Growth Stock in the Midst of Consolidation.

Via Chartmill

DexCom (DXCM) Q2 2024 Earnings Call Transcript ↗

July 25, 2024

DXCM earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Walt Disney, Eli Lilly, AST SpaceMobile, DexCom, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

July 25, 2024

On Thursday, major U.S. indices showed mixed results. The Dow Jones Industrial Average increased by 0.2% to 39,935.07.

Via Benzinga

Topics Stocks

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors

July 25, 2024

From Law Offices of Howard G. Smith

Via Business Wire

DXCM Stock Earnings: DexCom Beats EPS, Misses Revenue for Q2 2024 ↗

July 25, 2024

DXCM stock results show that DexCom beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Dexcom Stock Collapses 33% After Sales Miss Leads To $25 Million Guidance Cut ↗

July 25, 2024

Shares are poised to open Friday at their lowest point since April 2022.

Via Investor's Business Daily

Topics Earnings

Nasdaq 100 Falls To 7-Week Lows, Marks Worst 2-Day Drop In Nearly 2 Years As Tech Rout Rages On ↗

July 25, 2024

Nasdaq 100 index falls to its lowest level since June amid volatility. Despite a brief boost from Q2 GDP growth and decreasing prices, it dropped 4.7% in 2 sessions.

Via Benzinga

DexCom Stock Drops After Mixed Q2 Results, Weak Forward Guidance ↗

July 25, 2024

DexCom shares are dropping after the company reported its second-quarter financial results Thursday. Here's a look at the key figures from the report.

Via Benzinga

Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program

July 25, 2024

From DexCom, Inc.

Via Business Wire

Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers ↗

July 19, 2024

Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a...

Via Benzinga

2 Healthcare Stocks to Buy at a Discount ↗

July 14, 2024

Beaten-down stocks can sometimes present an opportunity.

Via The Motley Fool

Top 4 Must-Have Healthcare Stocks for Long-Term Growth

July 11, 2024

Investing in healthcare offers long-term growth and stability fueled by demographic trends, technological advancements, and rising demand.

Via MarketBeat

3 Breakthrough Medical Device Stocks to Invest In Now ↗

July 08, 2024

Uncover the potential of leading medical device stocks boasting solid fundamentals and a promising future ahead.

Via InvestorPlace

2 Top Growth Stocks to Buy With $1,000 ↗

July 04, 2024

These stocks have excellent track records of beating the market.

Via The Motley Fool

Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.

June 27, 2024

From DexCom, Inc.

Via Business Wire

Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034 ↗

June 25, 2024

These millionaire-maker stocks could turn a $50,000 investment into $1 million by 2034 if their growth trajectories remain intact.

Via InvestorPlace

Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey ↗

June 21, 2024

Learn why DexCom, TransDigm, and Datadog, three hyped stocks trading at rich valuations, may not be the best additions to your portfolio.

Via InvestorPlace

Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes

June 20, 2024

From DexCom, Inc.

Via Business Wire

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.